awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42770955-62DF3CF2-32EB-456E-8F85-A40334F7BCF1
Q42770955-62DF3CF2-32EB-456E-8F85-A40334F7BCF1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-62DF3CF2-32EB-456E-8F85-A40334F7BCF1
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.
P2860
Q42770955-62DF3CF2-32EB-456E-8F85-A40334F7BCF1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-62DF3CF2-32EB-456E-8F85-A40334F7BCF1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
830bab48ca3b76986406b17640a40b7d40afa6e9
P2860
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.